Product NDC: | 45963-753 |
Proprietary Name: | Glyburide (micronized) and Metformin Hydrochloride |
Non Proprietary Name: | Glyburide (micronized) and Metformin Hydrochloride |
Active Ingredient(s): | 5; 500 mg/1; mg/1 & nbsp; Glyburide (micronized) and Metformin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45963-753 |
Labeler Name: | Actavis Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076716 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110622 |
Package NDC: | 45963-753-04 |
Package Description: | 500 TABLET in 1 BOTTLE (45963-753-04) |
NDC Code | 45963-753-04 |
Proprietary Name | Glyburide (micronized) and Metformin Hydrochloride |
Package Description | 500 TABLET in 1 BOTTLE (45963-753-04) |
Product NDC | 45963-753 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glyburide (micronized) and Metformin Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110622 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Inc. |
Substance Name | GLYBURIDE; METFORMIN HYDROCHLORIDE |
Strength Number | 5; 500 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |